- Patient's Testimonial
A patient was 66 years old when he was diagnosed with Descending Colon cancer by the doctors in Dec.2009.
The patient started Dendritic Cell Therapy on the recommendation of doctors. The six doses were administered from 2/4/11 to 29/06/11 in the presence of Doctors.
A female patient was diagnosed with Sigmoid Colon Caner with liver Mets at the age of 42 in 2010. In due course of time she had gone very weak and her condition was deteriorating. She was given Chemotherapy twice, which deteriorated her condition further because of the complications of chemotherapy.
APAC BIOTECH strives to find roots of cancer - the world's alarming disease, by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives of cancer patients. In everything we do, we aim to fulfill our mission to serve patients from funding the next cutting-edge medical innovation to creatively working on patient treatment delivery. We are focused primarily on the development of cell based customized autologous therapy for cancer.
Cancer is a generic denomination, which includes different forms of the same illness. All types of cancer have in common, that a group of cells show uncontrolled growth which leads to the formation of tumors threatening the life of the patient. All cancers begin in cells, the body's basic unit of life. The cells grow and divide in a controlled way to produce more cells as they are needed to keep the body healthy. When cells become old or damaged, they die and are replaced with new cells.
However, sometimes this orderly process goes wrong. The genetic material (DNA) of a cell can become damaged or changed, producing mutations that affect normal cell growth and division. When this happens, cells do not die when they should and new cells form when the body does not need them. The extra cells may form a mass of tissue called a tumor.
APAC Biotech (P) Ltd, Gurgaon is now a member of the International Society for Dendritic Cell and Vaccine Sciences (DC Vaccine), a project of The Rockefeller University, New York, USA.